Protein degradation Archives - Inside Precision Medicine

Inside Precision Medicine Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders

Translucent robotic looking hand holding a test tube next to a screen showing code and a digital pill to symbolize the use of AI to develop new protein phase separation drugs

News & Features

Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders

Malorye Branca -

February 27, 2024

3D Rendering of Antibody Drug Conjugate Molecules

News & Features

BMS Pays $100M Upfront for Antibody Degrader Conjugate from Orum

Malorye Branca -

November 8, 2023

Rapamycin inhibiting protein kinase mTORC1

News & Features

Schreiber’s Magnet Emerges from Stealth to Develop Alternative Molecular Glues

Malorye Branca -

September 19, 2023

Rapamycin inhibiting protein kinase mTORC1

News & Features

Astellas and PeptiDream Ink $21M Plus Protein Degrader Deal

Malorye Branca -

July 25, 2023

Asked & Answered column photo

News & Features

Asked and Answered: Taking Protein Degradation to a New Therapeutic Frontier—Outside the Cell

Kathy Vuksanaj -

February 10, 2023

Scientific Experiment

News & Features

Blueprint Medicines, Proteovant Therapeutics Collaborate on Novel Targeted Protein Degrader Therapies

Chris Anderson -

March 2, 2022

Related Content

33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs

33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs

Small Molecule Shows Promise for Alternative Sickle Cell Disease Treatment

Small Molecule Shows Promise for Alternative Sickle Cell Disease Treatment

Molecular Defects in Lupus Presents Target for Therapy Development

Molecular Defects in Lupus Presents Target for Therapy Development

Killer Phage-Like Tails in Bacteria May Crack Microbial Drug Resistance

Killer Phage-Like Tails in Bacteria May Crack Microbial Drug Resistance